Litcius/Paper detail

<i>In Vitro</i>Exposure of Leukocytes to HIV Preexposure Prophylaxis Decreases Mitochondrial Function and Alters Gene Expression Profiles

Emily Bowman, Cheryl Cameron, Brian Richardson, Manjusha Kulkarni, Janelle Gabriel, Aaren Kettelhut, Lane Hornsby, Jesse J. Kwiek, Abigail Norris Turner, Carlos Malvestutto, José A. Bazan, Susan L. Koletar, Susanne Doblecki‐Lewis, Michael M. Lederman, Mark J. Cameron, Nichole R. Klatt, Jordan E. Lake, Nicholas Funderburg

2020Antimicrobial Agents and Chemotherapy16 citationsDOIOpen Access PDF

Abstract

The use of antiretroviral therapy (ART) as preexposure prophylaxis (PrEP) is an effective strategy for preventing HIV acquisition. The cellular consequences of PrEP exposure, however, have not been sufficiently explored to determine potential effects on health in individuals without HIV. In this study, peripheral blood mononuclear cells (PBMCs) from people without HIV were exposed to tenofovir disoproxil fumarate (TDF) or emtricitabine (FTC) overnight. Mitochondrial mass and function were measured by flow cytometry and an Agilent XFp analyzer.

Topics & Concepts

EmtricitabinePeripheral blood mononuclear cellFlow cytometryPre-exposure prophylaxisHuman immunodeficiency virus (HIV)In vitroTenofovirMedicineImmunologyPharmacologyBiologyAntiretroviral therapyViral loadMen who have sex with menGeneticsSyphilisHIV-related health complications and treatmentsHIV Research and TreatmentHIV/AIDS Research and Interventions
<i>In Vitro</i>Exposure of Leukocytes to HIV Preexposure Prophylaxis Decreases Mitochondrial Function and Alters Gene Expression Profiles | Litcius